Abilify Dosage and Administration
Links shared publicly online about this topic
U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated With Autistic Disorder In Patients
medicalnewstoday.com — “(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Appl” View full resource at medicalnewstoday.com
Most Recently Shared on November 28, 2009 at 11:28 am By:
MNT Clinical Trials Health News
U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated.. http://bit.ly/51H21G
U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
drugs.com — “Abilify (aripiprazole) is used to treat irritability associated with autistic disorder in pediatric patients. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 24, 2009 at 12:10 am By:
FDA Approves Abilify for Irritability Associated with Autistic Disorder in Pediatric Patients - http://bit.ly/62jJ8P
Bipolar-disorder Related Drugs, Abilify, Quetiapine - Drugs - EverydayHealth.com
everydayhealth.com — “Find information on prescription and OTC drugs that treat Bipolar-disorder like Abilify, Abilify Discmelt, Aripiprazole, Calan, Calan SR, Carbamazepine, Carbatrol, Catapres, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3. Find medical information on side effects, drug interactions, dosage, and user ratings and reviews.” View full resource at everydayhealth.com
Most Recently Shared on April 8, 2010 at 3:09 am By:
Peter H Brown Doctor and Psychologist
Bipolar-disorder Related Drugs, Abilify, Quetiapine ... http://bit.ly/b62GaM #bipolar
FDA approves sNDA for pediatric autism drug ABILIFY
news-medical.net — “Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.” View full resource at news-medical.net
Most Recently Shared on November 21, 2009 at 9:29 am By:
Obesity News: FDA approves sNDA for pediatric autism drug ABILIFY: Bristol-Myers Squibb Company an.. http://twurl.nl/kl8lfe
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate - Business Wire - Wire - BradentonHerald.com
bradenton.com — “Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. , announced today that the U.S. Food and Drug Administration (FDA) has approved ABILIFY ® (aripiprazole) as an adjunct to the mood stabilizers lithium or valproate for the maintenance treatment of Bipolar I Disorder.” View full resource at bradenton.com
Most Recently Shared on February 17, 2011 at 5:02 pm By:
Peter H Brown Doctor and Psychologist
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I ... http://bit.ly/fnyJ5i #bipolar
FDA Approves New Dosage Strength for Intelence
drugs.com — “Intelence (etravirine) is used to treat HIV infection. Includes Intelence side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 4, 2011 at 4:10 am By:
Drugs and Devices OW OW Health
FDA Approves New Dosage Strength for Intelence: TITUSVILLE, N.J., Jan. 3, 2011 /PRNewswire/ -- The U.S. Fo... http://bit.ly/fCWTaJ #drug
FDA Recommends Lower Dosage for Painkiller Acetaminophen - TIME
time.com — “An FDA advisory panel has recommended that the maximum over-the-counter dose of the popular pain reliever acetaminophen, known as Tylenol, be lowered” View full resource at time.com
Most Recently Shared on July 1, 2009 at 2:41 pm By:
Dr. Suzann Wang Acupuncturist, CAM, and Naturopathic Doctor
New Tylenol guidelines, reading from @time http://bit.ly/z8cKp
CDC H1N1 Flu | Monovalent Influenza Vaccine Dosage, Administration, and Storage
cdc.gov — “CDC H1N1 Flu | Monovalent Influenza Vaccine Dosage, Administration, and Storage” View full resource at cdc.gov
Most Recently Shared on November 4, 2009 at 12:53 am By:
#HEALTH 2009 H1N1 Vaccine Dosage, Administration, and Storage http://ow.ly/15ZfBD
FDA Approves New Dosage Strength For INTELENCE(R)
medicalnewstoday.com — “The U.S. Food and Drug Administration(FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicate” View full resource at medicalnewstoday.com
Most Recently Shared on January 4, 2011 at 5:05 pm By:
MNT Drug Approvals Health News
FDA Approves New Dosage Strength For INTELENCE(R) http://mnt.to/3PBF #regulatory
Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths
drugs.com — “Simcor (niacin ER and simvastatin) is used for Hyperlipidemia. Information from Drugs.com includes Simcor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 1:29 am By:
Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths - http://bit.ly/aBBY2A
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin Extended-release/simvastatin)
medicalnewstoday.com — “Abbott has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. simcor is a fi” View full resource at medicalnewstoday.com
Most Recently Shared on December 12, 2009 at 12:22 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin: http://bit.ly/8fMHnz Full http://bit.ly/78Vmva
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)
medicalnewstoday.com — “Abbott (nyse: abt) has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. s” View full resource at medicalnewstoday.com
Most Recently Shared on December 11, 2009 at 3:19 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin: http://bit.ly/4HlCmF Full http://bit.ly/7vMN53
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency
medicalnewstoday.com — “Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreati” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2011 at 7:05 am By:
MNT Cystic Fibrosis Health News
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreati... http://mnt.to/3XfN
U.S. FDA Approves New 60 Mg Dosage Strength Of Fluoxetine
medicalnewstoday.com — “Edgemont Pharmaceuticals, LLC, a neuroscience focused company, announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg.” View full resource at medicalnewstoday.com
Most Recently Shared on October 13, 2011 at 9:05 am By:
MNT Drug Approvals Health News
U.S. FDA Approves New 60 Mg Dosage Strength Of Fluoxetine http://t.co/d38EVTiD #regulatory
APP Pharmaceuticals Announces Approval And Launch Of Gemcitabine HCI For Injection, USP In 2 Gram Dosage Form
medicalnewstoday.com — “APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA)” View full resource at medicalnewstoday.com
Most Recently Shared on May 19, 2011 at 12:07 pm By:
MNT Drug Approvals Health News
APP Pharmaceuticals Announces Approval And Launch Of Gemcitabine HCI For Injection, USP In 2 Gram Dosage Form http://mnt.to/3W67 #regulatory
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
Advertisement
